COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,547 Articles (22,881 medRxiv, 8,666 bioRxiv)

Most recent first Previous |  Page 1498: Articles 14971-14980  | Next

Evolutionary velocity with protein language models
Hie, B. L., Yang, K. K., Kim, P. S.
10.1101/2021.06.07.447389 — Posted: 2021-06-07
E156/G and Arg158, Phe-157/del mutation in NTD of spike protein in B.1.167.2 lineage of SARS-CoV-2 leads to immune evasion through antibody escape
Chaudhari, A., Kumar, D., Joshi, D. M., Patel, A., joshi, P. C.
10.1101/2021.06.07.447321 — Posted: 2021-06-07
Dynamics and self-assembly of the SARS-CoV-2 spike transmembrane domain
Lall, S., Balaram, P., Gosavi, S., Mathew, M. K.
10.1101/2021.06.07.447334 — Posted: 2021-06-07
In vitro evaluation of the effect of mutations in primer binding sites on detection of SARS-CoV-2 by RT-qPCR
Zimmermann, F., Urban, M., Krueger, C., Walter, M., Woelfel, R., Zwirglmaier, K.
10.1101/2021.06.07.447338 — Posted: 2021-06-07
FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome
Brevini, T., Maes, M., Webb, G. J., Gelson, W. T. H., Forrest, S., Mlcochova, P., Dillon, S., Varankar, S., Darvish-Damavandi, M., Mulcahy, V. L., Kuc, R. E., Williams, T. L., Galanakis, V., Vila-Gonzalez, M., Tysoe, O. C., Muraro, D., Crozier, T. W. M., Bargehr, J., Sinha, S., Upponi, S. S., Swift, L., Saeb-Parsy, K., Davies, S. E., Marjot, T., Barnes, E., Lohse, A. W., Moon, A. M., Barritt, S. A., Gupta, R. K., Baker, S., Davenport, A. P., Corbett, G., Buczacki, S. J. A., Lee, J.-H., Gibbs, P., Butler, A. J., Watson, C. J. E., Mells, G. F., Dougan, G., vallier, L., Sampaziotis, F.
10.1101/2021.06.06.446781 — Posted: 2021-06-07
Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152
Yadav, P. D., Sapkal, G., Ella, R., Sahay, R. R., Nyayanit, D. A., Patil, D. Y., Deshpande, G., Shete, A. M., Gupta, N., Mohan, V. K., Abraham, P., Panda, S., Bhargava, B.
10.1101/2021.06.05.447177 — Posted: 2021-06-07 Discussion: Onsite | Offsite
A Web Portal and Workbench for Biological Dissection of Single Cell COVID-19 Host Responses
Jin, K., Bardes, E. E., Mitelpunkt, A., Wang, Y. J., Bhatnagar, S., Sengupta, S., Krummel, D. P., Rothenberg, M. E., Aronow, B. J.
10.1101/2021.06.07.447287 — Posted: 2021-06-07
Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study
Ge, J., Pletcher, M. J., Lai, J. C., N3C Consortium
10.1101/2021.06.03.21258312 — Posted: 2021-06-07
Long-COVID following mild SARS CoV-2 infection: characteristic T cell alterations and response to antihistamines
Glynne, P., Tahmasebi, N., Gant, V. A., Gupta, R.
10.1101/2021.06.06.21258272 — Posted: 2021-06-07
Revealing public opinion towards COVID-19 vaccines using Twitter data in the United States: a spatiotemporal perspective
Hu, T., Wang, S., Luo, W., Yan, Y., Zhang, M., Huang, X., Liu, R., Ly, K., Kacker, V., Li, Z.
10.1101/2021.06.02.21258233 — Posted: 2021-06-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).